Our study found that MDMA promoted an MPP+-induced decrease in SH-SY5Y cell viability, promoted MPP+-induced inflammation-related protein expression and NO release, promoted SN neuronal injury, inhibited TH expression, and promoted the progression of PD. This evidence concerns the gene TH and Parkinson disease.